Metoprolol tartrate and Livedo reticularis - from FDA reports


Summary

Livedo reticularis is found among people who take Metoprolol tartrate, especially for people who are female, 60+ old also take medication Magnevist, and have Diabetes. This review analyzes which people have Livedo reticularis with Metoprolol tartrate. It is created by eHealthMe based on reports of 47,725 people who have side effects when taking Metoprolol tartrate from FDA , and is updated regularly.

What to expect?

If you take Metoprolol tartrate and have Livedo reticularis, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Metoprolol tartrate and have Livedo reticularis

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 23, 2017

47,725 people reported to have side effects when taking Metoprolol tartrate.
Among them, 19 people (0.04%) have Livedo reticularis


Number of reports submitted per year:

Could Metoprolol tartrate cause Livedo reticularis?

Gender of people who have Livedo reticularis when taking Metoprolol tartrate *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Livedo reticularis when taking Metoprolol tartrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 21.43 %
  • 50-59: 0.0 %
  • 60+: 78.57 %

Top conditions involved for these people *:

  • Nuclear Magnetic Resonance Imaging Abdominal (8 people, 42.11%)
  • Diabetes (8 people, 42.11%)
  • Ischaemic Heart Disease Prophylaxis (5 people, 26.32%)
  • Multiple Sclerosis (3 people, 15.79%)
  • Nausea (2 people, 10.53%)

Top co-used drugs for these people *:

  • Sensipar (13 people, 68.42%)
  • Optimark (13 people, 68.42%)
  • Omniscan (13 people, 68.42%)
  • Multihance (13 people, 68.42%)
  • Magnevist (13 people, 68.42%)

Top other side effects for these people *:

  • Weakness (18 people, 94.74%)
  • Skin Discoloration (14 people, 73.68%)
  • Pain (14 people, 73.68%)
  • Skin Hypertrophy (13 people, 68.42%)
  • Itching (13 people, 68.42%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Livedo reticularis when taking Metoprolol tartrate?

Expand the study to include all drugs with the same ingredients

Livedo reticularis and drugs with ingredients of metoprolol tartrate.

Expand the study to include reports from both FDA and eHealthMe

Livedo reticularis and Metoprolol tartrate from FDA and eHealthMe reports

Metoprolol tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 51,739 users)

Livedo reticularis

Livedo reticularis (a lace-like purplish discoloration of the skin) has been reported by people with high blood pressure, rheumatoid arthritis, multiple sclerosis, atrial fibrillation/flutter, pain (latest reports from 1,549 Livedo reticularis patients).

Browse all side effects of Metoprolol tartrate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Livedo reticularis

Livedo reticularis

Could your condition cause Livedo reticularis

Livedo reticularis

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Metoprolol tartrate and have Livedo reticularis.

Can you answer these questions?

More questions for: Metoprolol tartrate, Livedo reticularis

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Livedo reticularis